Literature DB >> 7380176

Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.

B J Potter, E Elias, H C Thomas, S Sherlock.   

Abstract

The fractional catabolic rate of C1q was increased markedly in primary biliary cirrhosis, and in HBsAg-positive chronic liver disease. In 3 out of 4 patients with HBSAg-negative chronic active liver disease C1q catabolism was normal. The rate of synthesis of the protein was increased in primary biliary cirrhosis, but it was normal in patients with chronic active liver disease. The fractional catabolic rate and synthetic rate of albumin were normal in these subjects. These data provide further evidence for the activation of the classical pathway of complement in primary biliary cirrhosis and HBsAg-positive chronic active liver disease. In HBsAg-negative chronic active liver disease, the presence of C1q binding macromolecules was not associated with increased C1q catabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380176

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

Review 3.  Primary biliary cirrhosis associated with features of systemic lupus erythematosus.

Authors:  G D Iliffe; S Naidoo; T Hunter
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

Review 4.  Pathogenic mechanisms in primary biliary cirrhosis.

Authors:  H C Thomas; O Epstein
Journal:  Springer Semin Immunopathol       Date:  1980-12

Review 5.  Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection.

Authors:  J L Dienstag
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 6.  Clinical, histologic, and immunopathologic features of primary biliary cirrhosis.

Authors:  H Popper; F Paronetto
Journal:  Springer Semin Immunopathol       Date:  1980-12

7.  Complement activation in chronic liver disease.

Authors:  L E Munoz; D De Villiers; D Markham; K Whaley; H C Thomas
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Complement profile in primary biliary cirrhosis.

Authors:  M Schlesinger; C Benbassat; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

9.  Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

Authors:  G Chen; P Karayiannis; M J McGarvey; A M Lever; J A McDonald; L J Scully; S Kanatakis; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.